scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1033581389 |
P356 | DOI | 10.1186/1471-2334-12-277 |
P932 | PMC publication ID | 3582549 |
P698 | PubMed publication ID | 23130818 |
P5875 | ResearchGate publication ID | 232960363 |
P50 | author | Amalia S Magaret | Q87912727 |
Jared M Baeten | Q89443633 | ||
Jairam R Lingappa | Q89741329 | ||
Patrick Ndase | Q117265888 | ||
Guy de Bruyn | Q40494331 | ||
Anna Wald | Q41122225 | ||
Connie Celum | Q42571941 | ||
Partners in Prevention HSV/HIV Transmission Study Team | Q42572226 | ||
P2860 | cites work | Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group | Q74213228 |
Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study | Q38876606 | ||
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration | Q38876759 | ||
Levels and causes of adult mortality in rural South Africa: the impact of AIDS. | Q39077610 | ||
Risk factors for domestic violence: findings from a South African cross-sectional study | Q39105497 | ||
Mortality and burden of disease in a cohort of HIV-seropositive adults in Nairobi, Kenya | Q40538841 | ||
The impact of HIV/AIDS on mortality and household mobility in rural Tanzania | Q42661420 | ||
Mortality in siblings of patients coinfected with HIV and hepatitis C virus | Q43034734 | ||
HIV incidence and HIV-associated mortality in a cohort of factory workers and their spouses in Tanzania, 1991 through 1996. | Q43613351 | ||
Immunodeficiency and the risk of death in HIV infection | Q44506022 | ||
Effect of HIV/AIDS-related mortality on household dependency ratios in rural South Africa, 2000-2005. | Q44919897 | ||
Socioeconomic disparities in access to HIV/AIDS treatment programs in resource-limited settings | Q45370055 | ||
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries | Q46391119 | ||
Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 | ||
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies | Q24656950 | ||
Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality | Q28475331 | ||
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group | Q29614934 | ||
Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial | Q33313869 | ||
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study | Q33436735 | ||
Coming home to die? The association between migration and mortality in rural South Africa | Q33470693 | ||
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk | Q33697958 | ||
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. | Q33727305 | ||
Effect of early versus deferred antiretroviral therapy for HIV on survival | Q33789114 | ||
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial | Q33881449 | ||
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study | Q34011661 | ||
Body mass index and risk of tuberculosis and death | Q34713831 | ||
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection | Q34740804 | ||
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study | Q34903835 | ||
Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications | Q35013711 | ||
Early versus standard antiretroviral therapy for HIV-infected adults in Haiti | Q36914021 | ||
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis | Q37718319 | ||
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda | Q38869763 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | multicenter clinical trial | Q6934595 |
anti-retroviral agent | Q50430310 | ||
P304 | page(s) | 277 | |
P577 | publication date | 2012-10-30 | |
P1433 | published in | BMC Infectious Diseases | Q15759919 |
P1476 | title | Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial | |
P478 | volume | 12 |